Anti-HNF-4-alpha antibody [EPR16786] - N-terminal
- RabMAb
- Advanced Validation
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal HNF-4-alpha antibody. N-terminal. Suitable for ChIC/CUT&RUN-seq, ChIP-seq, WB, ICC/IF, IHC-P and reacts with Human, Mouse, Rat samples. Cited in 4 publications.
View Alternative Names
HNF4, NR2A1, TCF14, HNF4A, Hepatocyte nuclear factor 4-alpha, HNF-4-alpha, Nuclear receptor subfamily 2 group A member 1, Transcription factor 14, Transcription factor HNF-4, TCF-14
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (AB199431)
Immunohistochemical analysis of paraffin-embedded Human hepatocellular carcinoma tissue labeling HNF-4-alpha with ab199431 at 1/400 dilution followed by Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/500 dilution. Nucleus staining on Human hepatocellular carcinoma tissue is observed. Counter stained with Hematoxylin.
Negative control : Used PBS instead of primary antibody secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ab97051).
Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.
- ChIP-seq
Supplier Data
ChIP-sequencing - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (AB199431)
Chromatin was prepared from HepG2 (Human liver hepatocellular carcinoma cell line) cells. ChIP was performed with 10^7 HepG2 cells and 8 µg of ab199431 [EPR16786]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads.
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (AB199431)
ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2 x 10^5 HepG2 (Human liver hepatocellular carcinoma cell line) cells and 5 µg of ab199431 [EPR16786]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. The ChIP data was conducted on chromatin prepared from HepG2 cells. ChIP was performed with 10^7 HepG2 cells and 8 µg of ab199431 [EPR16786]. ChIP DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 30 million reads. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (AB199431)
Immunofluorescent analysis of 4% paraformaldehyde-fixed 0.1% Triton X-100 permeabilized HepG2 (Human liver hepatocellular carcinoma) cells labeling HNF-4-alpha with ab199431 at 1/250 dilution followed by Goat anti-rabbit IgG (Alexa Fluor® 488) (ab150077) secondary antibody at 1/500 dilution (green). Nuclear staining on HepG2 cell line is observed. The nuclear counterstain is DAPI (blue). Tubulin is detected with ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution and ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution (red).
The negative controls are as follows : -
-ve control 1 - ab199431 at 1/250 dilution followed by ab150120 (AlexaFluor®594 Goat anti-Mouse secondary) at 1/500 dilution.
-ve control 2. - ab7291 (anti-Tubulin mouse mAb) at 1/1000 dilution followed by ab150077 (Alexa Fluor®488 Goat Anti-Rabbit IgG H&L) at 1/500 dilution.
- WB
Supplier Data
Western blot - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (AB199431)
This antibody can recognize 3 isoforms. The predicted MW are 53KDa, 52 KDa and 47KDa, respectively.
Blocking/dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (ab199431) at 1/10000 dilution
Lane 1:
Mouse liver tissue lysate at 10 µg
Lane 2:
Rat liver tissue lysate at 10 µg
Lane 3:
Human fetal liver tissue lysate at 10 µg
Lane 4:
Human stomach tissue lysate at 10 µg
Secondary
All lanes:
Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1000 dilution
Predicted band size: 53 kDa,84 kDa
Observed band size: 47 kDa,53 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (AB199431)
This antibody can recognize 3 isoforms. The predicted MW are 53KDa, 52 KDa and 47KDa, respectively.
Blocking/dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-HNF-4-alpha antibody [EPR16786] - N-terminal (ab199431) at 1/10000 dilution
All lanes:
HepG2 (Human liver hepatocellular carcinoma) whole cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 53 kDa
Observed band size: 47 kDa,53 kDa
false
Exposure time: 1min
Related conjugates and formulations (4)
-
HRP Anti-HNF-4-alpha antibody [EPR16786] - N-terminal
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-HNF-4-alpha antibody [EPR16786] - N-terminal
-
Anti-HNF-4-alpha antibody [EPR16786] - BSA and Azide free
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-HNF-4-alpha antibody [EPR16786] - N-terminal
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
HNF-4-alpha influences the expression of genes involved in liver and pancreatic function. It acts as a transcriptional regulator that controls fatty acid oxidation gluconeogenesis and insulin secretion. HNF-4-alpha interacts with other proteins to form transcriptional complexes that fine-tune the expression of metabolic enzymes and transport proteins. This protein is key to ensuring that metabolic genes are expressed in a coordinated manner which is essential for maintaining normal metabolic processes.
Pathways
HNF-4-alpha participates in the insulin signaling and lipid metabolism pathways. Through these pathways it interacts with other transcription factors such as HNF-1-alpha and PPAR-alpha which coordinate the regulation of genes involved in glucose metabolism and fatty acid oxidation. HNF-4-alpha plays a critical role by modulating the expression of enzymes like gluconeogenic enzymes in response to metabolic needs which connects it to key metabolic pathways influencing overall energy homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download chicCutRunSequencingBooklet|en
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular sciences 24: PubMed36982757
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 50:7959-7971 PubMed35871292
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 233:4770-4782 PubMed29150932
2018
Applications
Unspecified application
Species
Unspecified reactive species
The American journal of pathology 187:2775-2787 PubMed28919113
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com